NL-OMON20286招募中不适用
Pharmacokinetics of clindamycin in overweight patients
Gelre Hospitals, Apeldoorn/ZutphenAlbert Schweitzerlaan 31 7334 DZ Apeldoorn0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age > 18 years
- •- Treatment at regular dosing intervals with intravenous or oral clindamycin for at least 48 hours on day of blood sampling. Subject can be included twice if route of administration changes.
排除标准
- •- Administration of medication with a known pharmacokinetic interaction ( e.g. rifampicin, HIV protease inhibitors.
- •- Inability to understand the nature of the trial and the procedures required.
研究者
相似试验
已完成
不适用
Pharmacokinetics of clindamycin in overweight patientsNL-OMON45669Gelre Ziekenhuizen40
招募中
不适用
Obesity effect on the characteristics of the blood-thinning drug rivaroxabavenous thromboembolismobesityatrial fibrillationACTRN12622000297729Medical Research Center, Hamad Medical Corporation81
招募中
1 期
Clindamycin pharmacokinetics during obstetric or fetal surgeryProphylaxis (antibiotics) during maternal or fetal surgeryCTIS2023-503653-35-00Z Leuven
已完成
1 期
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With AcneAcne VulgarisNCT01132443Stiefel, a GSK Company72
Unknown
不适用
Study of Obese Patients Comparing Two Vancomycin Loading Dose RegimensInfectionObesitySepsisNCT02764359CAMC Health System128